| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/10/2005 | US6891023 Antibodies and Fv fragment recognizing antigen IOR C2 |
| 05/10/2005 | US6890899 A lipolytic or lipid mobilising factor (LMF) produced by the cachexia-inducing murine tumor MAC16; weight reduction or controlling obesity; administering a Zn-alpha 2-glycoprotein |
| 05/10/2005 | US6890736 For diagnostics/pharmacology/therapeutics/nutraceuticals; improved efficiency; serum-free; genetic engineering |
| 05/10/2005 | US6890731 For drug screeing/therapy of diseases; bacteriophages |
| 05/10/2005 | US6890722 HP biopolymer markers predictive of insulin resistance |
| 05/10/2005 | US6890717 For diagnostics/screening assays/hybridization probes/primers/therapy for osteoporosis/periodontal disease |
| 05/10/2005 | US6890710 For treating influenza infections in vivo; fusion proteins; solid phase synthesis |
| 05/10/2005 | US6890554 Genetic immunization with cationic lipids |
| 05/10/2005 | US6890537 Antigrowth agents; microbiocides, bactericides |
| 05/10/2005 | US6890534 Aiolos genes and polypeptides of the present invention are useful for studying, diagnosing and/or treating diseases associated with unwanted cell proliferation, e.g., leukemias or lymphomas |
| 05/10/2005 | US6890532 Postexposure prophylaxis therapy |
| 05/10/2005 | US6890529 Edible foods, functional products or pharmaceuticals; nutraceutical; beverages |
| 05/10/2005 | CA2340712C Method and device for carrying out biochemical reactions with a high throughput |
| 05/10/2005 | CA2330935C A mutant human hepatitis b viral strain and uses thereof |
| 05/10/2005 | CA1341482C Process for preparing fragments of aids-associated retroviruses |
| 05/06/2005 | WO2005040395A1 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
| 05/06/2005 | WO2005040386A2 A vector modification for versatile use of expressed products |
| 05/06/2005 | WO2005040364A1 Novel recombinant animal cells with high protein production, method of constructing the same and method of mass protein production using the same |
| 05/06/2005 | WO2005039607A1 The use of balloonfish collagen i extractive in medical care and the preparative method of it |
| 05/06/2005 | WO2005019466A3 Process for the preparation of recombinant polypeptides |
| 05/06/2005 | WO2005017116A3 Thermostable peroxide-driven cytochrome p450 oxygenase variants and methods of use |
| 05/06/2005 | WO2005014848A3 IMPROVED ELECTROPHYSIOLOGICAL ASSAYS USING OOCYTES THAT EXPRESS HUMAN ENaC AND THE USE OF PHENAMIL TO IMPROVE THE EFFECT OF ENaC ENHANCERS IN ASSAYS USING MEMBRANE POTENTIAL REPORTING DYES |
| 05/06/2005 | WO2005002502A3 An assay for detecting the presence of processing inhibitory antibodies against the apical membrane antigene-1 of plasmodium falciparum in biological samples |
| 05/06/2005 | WO2005000223A3 Method of treating retinopathies and disorders associated with blood vessel loss |
| 05/06/2005 | WO2004106508A3 Bioreactor containing cells expressing glycosyltransferase nucleic acids |
| 05/06/2005 | WO2004091495A3 Compositions and methods related to production of erythropoietin |
| 05/06/2005 | WO2004081027B1 Neoplasm specific antibodies and uses thereof |
| 05/06/2005 | WO2004078933A3 Intracellular delivery of small molecules proteins and nucleic acids |
| 05/06/2005 | WO2003068146A3 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 05/06/2005 | CA2826733A1 High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of mar sequences |
| 05/06/2005 | CA2541506A1 Immunogenic compostion and method of developing a vaccine based on psoralen inactivated hiv |
| 05/06/2005 | CA2541492A1 Immunogenic composition and method of developing a vaccine based on fusion protein |
| 05/05/2005 | US20050097639 Abiotic stress tolerance protein for use as tool in generating drought resistant crop plants |
| 05/05/2005 | US20050097627 Transgenic ungulates having reduced prion protein activity and uses thereof |
| 05/05/2005 | US20050097625 Generating trangenic mammal in which somatic and germ cell comprisie heavy chain variable region of immunoglobulins; bioreactors for production of preferential immunoglobulins in milk |
| 05/05/2005 | US20050096458 GENSET polynucleotides and polypeptides used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, expression vectors production; screening/diagnosis assays for abnormal GENSET expression and/or biological activity; gene therapy; genomics |
| 05/05/2005 | US20050096277 Methods of prevention and treatment using apolipoprotein analogues |
| 05/05/2005 | US20050096271 Fusion of polypeptides and immunoglobulin protein; immunotherapy ; antiallergens; antiarthritic agents; anticancer agents; antiinflammatory agents |
| 05/05/2005 | US20050095712 Mutations caused by activation-induced cytidine deaminase |
| 05/05/2005 | US20050095690 Entrapment of biomolecules and inorganic nanoparticles by biosilicification |
| 05/05/2005 | US20050095679 Using bacillus as bioreactor for fermentation of high molecular weight poly-gamma-glutamic acid (PGA) for use as constituent in medicine and foods |
| 05/05/2005 | US20050095667 Oligomeric lysine-aspartic acid-glutamic acid-leucine amino acid sequence binding protein suppressor; for amplification of immune response to secreted chaperone proteins |
| 05/05/2005 | US20050095650 screening for an agent that modulates capsaicin receptor function |
| 05/05/2005 | US20050095612 isolated antibody that specifically binds to polypeptides for diagnosing, preventing and treating autoimmune, cancer and transplant disorders; wound healing agents |
| 05/05/2005 | US20050095584 Method for determining early HCV seroconversion |
| 05/05/2005 | US20050095581 Viral polypeptide for use as tool in generating immunoreactive particle for diagnosis, prevention and treatment of viral infection |
| 05/05/2005 | US20050095256 Nucleotide sequence encoding merozoite surface protein-1 of plasmodium strain with reduced adenine and thymine; vectors, organisms, host cells |
| 05/05/2005 | US20050095249 Protein markers for lung cancer and use thereof |
| 05/05/2005 | US20050095236 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84 |
| 05/05/2005 | US20050092684 Novel colostral fractionation process |
| 05/04/2005 | EP1528103A1 'Osteoclast-inhibitory factor' (OCIF) derived proteins and methods for producing the proteins |
| 05/04/2005 | EP1527190A2 Hip1 cancer markers |
| 05/04/2005 | EP1527189A2 Mutant proteinase inhibitors and uses thereof |
| 05/04/2005 | EP1527188A1 Process for the production of increased amounts of correctly folded heterologous protein in inclusion bodies |
| 05/04/2005 | EP1527164A2 Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor |
| 05/04/2005 | EP1527100A2 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 05/04/2005 | EP1527098A2 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof |
| 05/04/2005 | EP1527095A1 SYNTHETIC GENE CODING FOR HUMAN GRANULOCYTE-COLONY STIMULATING FACTOR FOR THE EXPRESSION IN E. coli |
| 05/04/2005 | EP1527085A2 Antigens and their use as diagnostics and vaccines against species of plasmodium |
| 05/04/2005 | EP1499747A4 Formation and use of site specific nucleic acid coupled binding polypeptides |
| 05/04/2005 | EP1362062B1 Concatameric immunoadhesion |
| 05/04/2005 | EP1124984A4 Host cells expressing recombinant human erythropoietin |
| 05/04/2005 | EP1012307B1 Zymogenic protease precursors that can be autocatalytically activated and their use |
| 05/04/2005 | EP0781340B1 Vaccine against group A Streptococcal infection |
| 05/04/2005 | EP0777737B1 Non-toxic, non-toxigenic, non-pathogenic fusarium expression system and promoters and terminators for use therein |
| 05/04/2005 | EP0672139B1 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof |
| 05/04/2005 | EP0668916B1 Haemophilus outer membrane protein |
| 05/04/2005 | CN1612942A Viral capsid assembly intermediates |
| 05/04/2005 | CN1612934A Human monoclonal antibodies to dendritic cells |
| 05/04/2005 | CN1612896A Peptide purification by means of metal ion affinity chromatography |
| 05/04/2005 | CN1612895A Conjugates comprising an antibody specific for the ED-B domain of fibronectin and their use for the detection and treatment of tumours |
| 05/04/2005 | CN1612890A Novel chimeric tnf ligands |
| 05/04/2005 | CN1612691A Methods and compositions for correction of cardiac conduction disturbances |
| 05/04/2005 | CN1611605A Method for producing human leukemia inhibitory factor using transgenic plant |
| 05/04/2005 | CN1611603A Novel DNA fragment and its inhibition from tumour |
| 05/04/2005 | CN1611513A Process of high purity albumin production |
| 05/04/2005 | CN1200002C Human melanin tumour monoclonal antibody, and its preparing method and use |
| 05/04/2005 | CN1199999C Human protein for promoting transform of 3T3 cell and its coding sequence |
| 05/04/2005 | CN1199998C Human protein with suppression to cance cell growth and its coding sequence |
| 05/04/2005 | CN1199997C New human protein having mouse NIH/3T3 cell conversion promoting function and its coding sequence |
| 05/04/2005 | CN1199996C New human protein having cancer cell growth in hibiting function and its coding sequence |
| 05/04/2005 | CN1199995C New Human protein having cancer inhibiting function and its coding sequence |
| 05/04/2005 | CN1199994C New human protein with cancer cell growth inhibiting function and its coding sequence |
| 05/04/2005 | CN1199693C Remedies for hypercalcemic crisis |
| 05/04/2005 | CN1199567C Hybrid matrix implants and explants |
| 05/03/2005 | US6887987 DNA encoding the human serine protease T |
| 05/03/2005 | US6887981 Natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof |
| 05/03/2005 | US6887978 Vanilloid receptor |
| 05/03/2005 | US6887975 Serpentine protein for use in the treatment of cancer |
| 05/03/2005 | US6887844 To stimulate the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM) |
| 05/03/2005 | US6887683 Human G-protein coupled receptors |
| 05/03/2005 | US6887674 Artery- and vein-specific proteins and uses therefor |
| 05/03/2005 | US6887673 Containing light chain and a heavy chain peptide; anticarcinogenic agent |
| 05/03/2005 | US6887670 For drug screening; solid phase synthesis; fusion proteins; genetic engineering |
| 05/03/2005 | US6887661 Recombinant bHLH-PAS/JHR polypeptide and its use to screen potential insecticides |
| 05/03/2005 | US6887660 Detecting cancer in humans; obtain sample, incubate with binding protein, detect bound proteins or polypeptides, presence of bound protein indicates cancer |
| 05/03/2005 | US6887659 A quantitative analyzing the concentration of peptide with monoclonal antibody produced by the fused cell hybrid; medical diagnosis |
| 05/03/2005 | US6887473 Administering as antitumor, antimetastasis, antiinflammatory, or anticarcinogenic agent |
| 05/03/2005 | US6887468 Antibody kits for selectively inhibiting VEGF |
| 05/03/2005 | CA2147623C Novel p-selectin ligand protein |